The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care
Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient access, according to experts.
Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care
An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.
